Literature DB >> 1999483

Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.

J K Gwathmey1, S E Warren, G M Briggs, L Copelas, M D Feldman, P J Phillips, M Callahan, F J Schoen, W Grossman, J P Morgan.   

Abstract

We tested the hypothesis that intracellular Ca++ [( Ca++]i) overload underlies the diastolic dysfunction of patients with hypertrophic cardiomyopathy. Myocardial tissue was obtained at the time of surgery or transplantation from patients with hypertrophic cardiomyopathy and was compared with control myocardium obtained from patients without heart disease. The isometric contractions and electrophysiologic properties of all myocardial specimens were recorded by standard techniques and [Ca++]i was measured with the bioluminescent calcium indicator aequorin. In contrast to the controls, action potentials, Ca++ transients, and isometric contraction and relaxation were markedly prolonged in the hypertrophic myocardium, and the Ca++ transients consisted of two distinct components. At 38 degrees C and 1 Hz pacing frequency, a state of relative Ca++ overload appeared develop, which produced a rise in end-diastolic [Ca++]i, incomplete relaxation, and fusion of twitches with a resultant decrease in active tension development. We also found that drugs with increase [Ca++]i, such as digitalis, exacerbated these abnormalities, whereas drugs that lower [Ca++]i, such as verapamil, or agents that increase cyclic AMP, such as forskolin, prevented them. These results may explain why patients with hypertrophic cardiomyopathy tolerate tachycardia poorly, and may have important implications with regard to the pharmacologic treatment of patients with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999483      PMCID: PMC329896          DOI: 10.1172/JCI115061

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  [Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)].

Authors:  M Kaltenbach; R Hopf; M Keller
Journal:  Dtsch Med Wochenschr       Date:  1976-08-27       Impact factor: 0.628

2.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

3.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

Authors:  J E Sanderson; D G Gibson; D J Brown; J F Goodwin
Journal:  Br Heart J       Date:  1977-06

4.  Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.

Authors:  B H Lorell; W J Paulus; W Grossman; J Wynne; P F Cohn; E Braunwald
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

5.  Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child.

Authors:  S D Beder; H P Gutgesell; C E Mullins; D G McNamara
Journal:  Am Heart J       Date:  1982-07       Impact factor: 4.749

Review 6.  Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

7.  Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy.

Authors:  P Hanrath; D G Mathey; P Kremer; F Sonntag; W Bleifeld
Journal:  Am J Cardiol       Date:  1980-06       Impact factor: 2.778

8.  Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade.

Authors:  L S Cohen; E Braunwald
Journal:  Circulation       Date:  1967-05       Impact factor: 29.690

9.  Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.

Authors:  B H Lorell; W J Paulus; W Grossman; J Wynne; P F Cohn
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

10.  Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity.

Authors:  B F Waller; B J Maron; S E Epstein; W C Roberts
Journal:  Chest       Date:  1981-04       Impact factor: 9.410

View more
  36 in total

Review 1.  LV hypertrophy and diastolic heart failure.

Authors:  S Betocchi; O M Hess
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

2.  Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects.

Authors:  Quirino Ciampi; Sandro Betocchi; Anna Violante; Raffaella Lombardi; Maria Angela Losi; Giovanni Storto; Fiore Manganelli; Carlo Gabriele Tocchetti; Mariano Aversa; Elpidio Pezzella; Filippo Finizio; Alberto Cuocolo; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Diastolic Heart Failure.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

4.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

5.  Early diastolic function during exertion influences exercise intolerance in patients with hypertrophic cardiomyopathy.

Authors:  Kei Mizukoshi; Kengo Suzuki; Kihei Yoneyama; Ryo Kamijima; Seisyou Kou; Manabu Takai; Masaki Izumo; Akio Hayashi; Eiji Ohtaki; Yoshihiro J Akashi; Naohiko Osada; Kazuto Omiya; Tomoo Harada; Sachihiko Nobuoka; Fumihiko Miyake
Journal:  J Echocardiogr       Date:  2012-10-19

6.  Calcium handling proteins: structure, function, and modulation by exercise.

Authors:  Jamille Locatelli; Leonardo V M de Assis; Mauro C Isoldi
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

8.  Phospholamban phosphorylation, mutation, and structural dynamics: a biophysical approach to understanding and treating cardiomyopathy.

Authors:  Naa-Adjeley D Ablorh; David D Thomas
Journal:  Biophys Rev       Date:  2015-01-21

9.  Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity.

Authors:  Khalid Abozguia; Ganesh Nallur-Shivu; Thanh T Phan; Ibrar Ahmed; Rajat Kalra; Rebekah A Weaver; William J McKenna; John E Sanderson; Perry Elliott; Michael P Frenneaux
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

10.  Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.

Authors:  D Fatkin; M E Christe; O Aristizabal; B K McConnell; S Srinivasan; F J Schoen; C E Seidman; D H Turnbull; J G Seidman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.